|
Market Closed -
Nasdaq
16:00:00 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 4.870 USD | +0.62% |
|
-2.01% | -2.99% |
| 08-12 | Annexon, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 08-12 | Annexon, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ANNEXON, INC. | Bio Therapeutic Drugs | +0.62% | -2.01% | -2.99% | +124.42% | -71.60% | 923M |  |  |  |
- Stock Market
- Stocks
- ANNX Stock
- Charts Annexon, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
